02-30783. New Animal Drugs for Use in Animal Feeds; Lasalocid  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule; technical amendment.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Purina Mills, Inc. The NADA provides for the use of a lasalocid Type A medicated article to make free-choice Type C medicated feed mineral blocks used for increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers).

    DATES:

    This rule is effective December 5, 2002.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Amey L. Adams, Center for Veterinary Medicine (HFV-126), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-7560, e-mail: aadams1@cvm.fda.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Purina Mills, Inc., P.O. Box 66812, St. Louis, MO 63166-6812, filed NADA 141-171 that provides for use of BOVATEC 68 (lasalocid) Type A medicated article to make Purina Sugar Mag Block 1440 BVT Medicated Mineral Block, a free-choice Type C medicated feed. The free-choice mineral block is used for increased rate of weight gain in pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers). The NADA is approved as of August 20, 2002, and the regulations are amended in § 558.311 (21 CFR 558.311) to reflect the approval. The basis of approval is discussed in the freedom of information summary.

    In addition, § 558.311 is being amended to collocate the entry for another free-choice mineral Type C medicated feed, approved under NADA 138-993, to the new entry created for NADA 141-171. This is being done to improve the readability and clarity of the regulations.

    In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.

    Under section 512(c)(2)(F)(ii) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b(c)(2)(F)(ii)), this approval qualifies for 3 years of marketing exclusivity beginning August 20, 2002.

    The agency has determined under 21 CFR 25.33(a)(6) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.

    This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

    Start List of Subjects

    List of Subjects in 21 CFR Part 558

    • Animal drugs
    • Animal feeds
    End List of Subjects Start Amendment Part

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:

    End Amendment Part Start Part

    PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

    End Part

    1. The authority citation for 21 CFR part 558 continues to read as follows:

    Start Authority

    Authority: 21 U.S.C. 360b, 371.

    End Authority Start Amendment Part

    2. Section 558.311 is amended by adding paragraph (b)(8); in paragraph (d)(7) by adding “and (e)(1)(xviii)” after “(e)(1)(xii)”; by revising (e)(1)(xii); and by adding paragraph (e)(1)(xviii) to read as follows:

    End Amendment Part
    Lasalocid.
    * * * * *

    (b) * * *

    (8) 15 percent activity to No. 017800 for use as in paragraph (e)(1)(xviii) of this section.

    * * * * *

    (e) * * *

    (1) * * *

    Start Printed Page 72369
    Lasalocid sodium activity in grams per tonCombination in grams per tonIndications for useLimitationsSponsor
    *         *         *         *         *         *         *
    (xii)Pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers): For increased rate of weight gain. Intakes of lasalocid in excess of 200 mg/head/day have not been shown to be more effective than 200 mg/head/day.Feed continuously on a free-choice basis at a rate of not less than 60 mg or more than 300 mg of lasalocid per head per day.046573
    *         *         *         *         *         *         *
    (xviii) 1440Pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers): For increased rate of weight gain.Feed continuously on a free-choice basis at a rate of not less than 60 mg nor more than 200 mg of lasalocid per head per day.021930 017800
    * * * * *
    Start Signature

    Dated: November 8, 2002.

    Stephen F. Sundlof,

    Director, Center for Veterinary Medicine.

    End Signature End Supplemental Information

    [FR Doc. 02-30783 Filed 12-4-02; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Effective Date:
12/5/2002
Published:
12/05/2002
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; technical amendment.
Document Number:
02-30783
Dates:
This rule is effective December 5, 2002.
Pages:
72368-72369 (2 pages)
PDF File:
02-30783.pdf
CFR: (1)
21 CFR 558.311